GSA Capital Partners’s BioAtla BCAB Stock Holding History

GSA Capital Partners’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,663	Closed	-$81K	–	1750
2025 Q1	$81K	Sell	4,663 -2,352	-34%	-$50.3K	0.01%	1522
2024 Q4	$207K	Sell	7,015 -60	-0.8%	-$5.04K	0.02%	1397
2024 Q3	$623K	Buy	+7,075	New	+$593K	0.05%	773
2024 Q2	–	Sell	-354	Closed	-$61K	–	1626
2024 Q1	$61K	Buy	+354	New	+$44K	﹤0.01%	1525
2022 Q2	–	Sell	-656	Closed	-$164K	–	1404
2022 Q1	$164K	Buy	+656	New	+$274K	0.02%	1218

Other funds holding BCAB

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

GSA Capital Partners's BCAB Position: Q2 2025 in Review

GSA Capital Partners sold out of BioAtla (BCAB) in Q2 2025, closing a stake of 4,663 shares — an estimated $81K sold.

GSA Capital Partners first reported a position in BCAB in Q1 2022 and held it in 5 quarters. The position peaked at $623K in Q3 2024. 39 funds tracked by Wall St. Rank hold BCAB as of Q2 2025.

GSA Capital Partners reported no remaining BioAtla position as of Q2 2025 after selling out during the quarter.
GSA Capital Partners sold 4,663 BioAtla shares in Q2 2025, an estimated $81K.
GSA Capital Partners first reported a position in BioAtla in Q1 2022 and held it in 5 quarters.
GSA Capital Partners's BioAtla position peaked at $623K in Q3 2024.
39 funds tracked by Wall St. Rank held BioAtla as of Q2 2025.

Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.